The EU did a Brexit trade deal with the pharma industry: it tried to lock in a perceived short-term price advantage at the expense of everything else. Instead of prioritising the speed and security of supplies at any price, the EU prioritised the price. The EU paid 24% less for the Pfizer vaccine than the US, for example. For the Oxford/AstraZeneca vaccine, the price gap is 45%. The UK almost certainly paid a lot more. It is no wonder that the manufacturers are prioritising orders on a first-come, first-serve basis, and from countries that pay the full price. The price difference is macroeconomically irrelevant. But if vaccine shortages lead to longer lockdowns, the indirect effect of that short-sighted policy will be massive.
Related Articles

Fake News
‘Internal memos of the upper class’: Gary Younge says journalism is out of touch
March 7, 2024
Mathew D. Rose
Fake News, Media, Media Concentration, Media Influence, National Politics, Racism
0
Former Guardian journalist says “sometimes ‘dog bites man’ really is the story. The trouble is journalists keep missing it.” Read HERE

EU politics
Politico – Brussels approves Germany’s mega spending plan
September 16, 2025
Ben Wray
EU politics, EU-Institutions, National Politics, Neo-Liberalism in the EU
0
EU spending limits are only for nurses and hospitals, not bombs, and only for countries like Greece and Portugal, not Germany. Read the article HERE.

Austerity
Simon Wren-Lewis: Decreasing the size of the state is very unpopular
February 9, 2018
Mathew D. Rose
Austerity, Deregulation, Economics, Finance, Media, Media Influence, Neo-Liberalism in the EU, Tax
0
Why? Why have we been told for decades that people are fed up with state intervention and state run companies? It is not only the bubble politicians live in. Wren-Lewis fails to mention the integral […]
Be the first to comment